These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 10995915)

  • 21. A Population Pharmacokinetic Model to Predict the Individual Starting Dose of Tacrolimus Following Pediatric Renal Transplantation.
    Andrews LM; Hesselink DA; van Gelder T; Koch BCP; Cornelissen EAM; Brüggemann RJM; van Schaik RHN; de Wildt SN; Cransberg K; de Winter BCM
    Clin Pharmacokinet; 2018 Apr; 57(4):475-489. PubMed ID: 28681225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of tacrolimus in paediatric renal transplant recipients.
    Webb NJ; Stevenson PJ; Lewis MA; Postlethwaite RJ; Bradbury MG; Undre N
    Transplant Proc; 2002 Aug; 34(5):1948-50. PubMed ID: 12176639
    [No Abstract]   [Full Text] [Related]  

  • 23. Early pharmacokinetic profiles of enteral tacrolimus after multivisceral transplantation.
    Hansen LJ; Puzycz P; Gooi HC; Lodge P; Pollard S
    Transplant Proc; 1997 May; 29(3):1861. PubMed ID: 9142303
    [No Abstract]   [Full Text] [Related]  

  • 24. Study of pharmacokinetic parameters of tacrolimus by different oral administration periods in renal transplantation.
    Saito K; Suwa M; Nakagawa Y; Utsugi R; Tanikawa T; Tomita Y; Takahashi K
    Transplant Proc; 2002 Aug; 34(5):1726-9. PubMed ID: 12176553
    [No Abstract]   [Full Text] [Related]  

  • 25. Tacrolimus dosing requirements in diabetic and nondiabetic patients calculated from pretransplantation data.
    van Duijnhoven E; Christiaans M; Schäfer A; Undre N; van Hooff J
    Transplant Proc; 1998 Jun; 30(4):1266-7. PubMed ID: 9636514
    [No Abstract]   [Full Text] [Related]  

  • 26. Therapeutic drug monitoring of once-daily tacrolimus (Advagraf) in a gastrectomized kidney transplant recipient.
    Ma TK; Chow KM; Kwan BC; Leung CB; Szeto CC; Li PK
    Nephrology (Carlton); 2017 Feb; 22(2):184. PubMed ID: 28064453
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical influencing factors for daily dose, trough level, and relative clearance of tacrolimus in renal transplant recipients.
    Hu RH; Lee PH; Tsai MK
    Transplant Proc; 2000 Nov; 32(7):1689-92. PubMed ID: 11119894
    [No Abstract]   [Full Text] [Related]  

  • 28. Prograf five milligrams versus Tacrolimus medis in healthy volunteers: a bioequivalence study.
    Masri M; Rizk S; Boujbel L; Bellahirich W; Baassoumi D; Attia M; Matha V
    Transplant Proc; 2013; 45(10):3453-7. PubMed ID: 24314930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sublingual tacrolimus: a pharmacokinetic evaluation pilot study.
    Tsapepas D; Saal S; Benkert S; Levine D; Delfin M; Cremers S; Amann S; Dadhania D; Kapur S; Aull M
    Pharmacotherapy; 2013 Jan; 33(1):31-7. PubMed ID: 23307542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The colon displays an absorptive capacity of tacrolimus.
    Nishi K; Ishii T; Wada M; Amae S; Sano N; Nio M; Hayashi Y
    Transplant Proc; 2004 Mar; 36(2):364-6. PubMed ID: 15050160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The roles of C4 and AUC0-4 in monitoring of tacrolimus in stable kidney transplant patients.
    Pisitkun T; Eiam-Ong S; Chusil S; Praditpornsilpa K; Pansin P; Tungsanga K
    Transplant Proc; 2002 Dec; 34(8):3173-5. PubMed ID: 12493410
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of breakfast on the oral bioavailability of tacrolimus in diabetic and nondiabetic patients before transplantation.
    van Duijnhoven E; Christiaans M; Undre N; Stevenson P; van Hooff J
    Transplant Proc; 1998 Jun; 30(4):1268-70. PubMed ID: 9636515
    [No Abstract]   [Full Text] [Related]  

  • 33. Tacrolimus clearance is age-dependent within the pediatric population.
    Przepiorka D; Blamble D; Hilsenbeck S; Danielson M; Krance R; Chan KW
    Bone Marrow Transplant; 2000 Sep; 26(6):601-5. PubMed ID: 11041564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Effect of P-Glycoprotein Inhibition and Activation on the Absorption and Serum Levels of Cyclosporine and Tacrolimus in Rats.
    Yigitaslan S; Erol K; Cengelli C
    Adv Clin Exp Med; 2016; 25(2):237-42. PubMed ID: 27627555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adequate exposure to tacrolimus with sublingual administration in pediatric liver transplant patients.
    Riva N; Galván ME; Cáceres-Guido P; Dip M; Licciardone N; Imventarza O; Schaiquevich P; Buamscha D
    Int J Clin Pharmacol Ther; 2017 Apr; 55(4):352-354. PubMed ID: 28079516
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacokinetic study of the combination of tacrolimus and fluconazole in renal transplant patients.
    Lumlertgul D; Noppakun K; Rojanasthien N; Kanchanarattanakorn K; Jittikanont S; Manoyot A; Bunnachak D; Ophascharoensuk V
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S73-8. PubMed ID: 17044457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modeling of Tacrolimus Exposure in Kidney Transplant According to Posttransplant Time Based on Routine Trough Concentration Data.
    Ben Fredj N; Woillard JB; Debord J; Chaabane A; Boughattas N; Marquet P; Saint-Marcoux F; Aouam K
    Exp Clin Transplant; 2016 Aug; 14(4):394-400. PubMed ID: 27506258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and bioavailability of tacrolimus in rats with experimental renal dysfunction.
    Okabe H; Hashimoto Y; Inui KI
    J Pharm Pharmacol; 2000 Dec; 52(12):1467-72. PubMed ID: 11197074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population pharmacokinetic analysis of mycophenolic acid coadministered with either tasocitinib (CP-690,550) or tacrolimus in adult renal allograft recipients.
    Lamba M; Tafti B; Melcher M; Chan G; Krishnaswami S; Busque S
    Ther Drug Monit; 2010 Dec; 32(6):778-81. PubMed ID: 20926996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacodynamics of the immunosuppressive effects of the combination of tacrolimus with mycophenolate mofetil.
    Barten MJ; Rahmel A; Richter M; Tarnok A; Bartsch P; Boeger M; Gehlhaar P; Dhein S; Mohr FW; Gummert JF
    Transplant Proc; 2002 Sep; 34(6):2372-3. PubMed ID: 12270442
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.